Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 12026-05-22NCT02632708

2 results · Page 1 of 1

Swipe the table sideways for more columns.

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Dana Farber Cancer InstituteBostonUnited States3
Erasmus MCRotterdamNetherlands3
Hackensack University Medical CenterHackensackUnited States308
Johns Hopkins UniversityBaltimoreUnited States13
Massachusetts General HospitalBostonUnited States1015
MD Anderson Cancer CenterHoustonUnited States589
Medical University of South Carolina - PPDSCharlestonUnited States1
Memorial Sloan Kettering Cancer CenterNew YorkUnited States60
Ohio State UniversityColumbusUnited States169
UCLA Medical CenterLos AngelesUnited States4
Universitatsklinikum UlmUlmGermany9
University of ChicagoChicagoUnited States312
University of ColoradoAuroraUnited States147
University of Texas Southwestern Medical CenterDallasUnited States249
Vanderbilt University Medical CenterNashvilleUnited States427
VU Medisch CentrumAmsterdamNetherlands16